A Risk Stratification Scheme for Synchronous Oligometastatic Non-Small Cell Lung Cancer Developed by a Multicentre Analysis

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality. Almost half of new NSCLC patients have stage IV disease at diagnosis. Stage IV patients are usually considered inoperable and treated solely with systemic therapy and/or palliative strategies [1]. The median survival was

Source: Lung Cancer - February 12, 2021 Category: Cancer & Oncology Authors: Lorenzo Spaggiari, Luca Bertolaccini, Francesco Facciolo, Filippo Tommaso Gallina, Federico Rea, Marco Schiavon, Stefano Margaritora, Maria Teresa Congedo, Marco Lucchi, Ilaria Ceccarelli, Marco Alloisio, Edoardo Bottoni, Giampiero Negri, Angelo Carretta, Source Type: research